The Second Annual Pharmaceutical Industry Regulatory & Compliance Summit


The Second Annual Pharmaceutical Industry Regulatory & Compliance Summit

THE SECOND ANNUAL PHARMACEUTICAL INDUSTRY REGULATORY & COMPLIANCE SUMMIT

June 10-12, 2001
Hyatt Regency
Crystal City
Arlington, VA


For future information about The Second Annual Pharmaceutical Industry Regulatory & Compliance Summit, please complete the form below.

First Name:  
Last Name:  
Email:  
   

Co-Sponsored By:
Health Care Compliance Association

In Association with:
Food and Drug Law Institute (FDLI)


The Second Annual Pharmaceutical Industry Regulatory & Compliance Summit
June 10-12, 2001
Download Brochure (272K)


Featured Speakers:


Anthony O. Boswell, Esq.
Corporate Compliance Officer and Corporate Counsel, Laidlaw, Inc.

Charles M. Brock, Esq.
Chief Ethics and Compliance Officer, AbbottLaboratories

Oliver M. Johnson, II, Esq.
Chief Privacy Officer, Merck & Co., Inc

Paul E. Kalb, MD, JD
Partner, Sidley & Austin

Richard J. Kenny, Jr., Esq.
Assistant General Counsel, AstraZeneca Pharmaceuticals, LP

Michael K. Loucks, Esq.
Health Care Fraud Chief, United States Attorney's Office, District of Massachusetts

Douglas M. Lankler, Esq.
Corporate Counsel, Compliance, Pfizer Inc.

Roger W. Louis, Esq.
Chief Compliance Officer, Genzyme Corporation

John Markus, Esq.
Senior Vice President, Fresenius Medical Care North America

Vickie McCormick, Esq.
Integrity Officer, UnitedHealth Group

Michael B. McCulley, Esq.
Assistant General Counsel, Johnson & Johnson

Joseph W. Metro, Esq.
Partner, Reed Smith, LLP

Lewis Morris, Esq.
Assistant Inspector General for Legal Affairs, Office of the Inspector General, US Department of Health and Human Services

Arjun Rajaratnam, Esq.
Compliance Officer, Global Pharmaceuticals, GlaxoSmithKline

Mary E. Riordan, Esq.
Senior Counsel, Office of Counsel to the Inspector General, HHS-OIG

Brent Saunders, JD, MBA
Director, PricewaterhouseCoopers and Founder, Privacy Officers Association

James Sheehan, Esq.
Assistant United States Attorney, United States Attorney's Office, Eastern District of Pennsylvania

Arvin P. Shroff, Ph.D.
Arvin Shroff Associates and Former Deputy Director, Office of Enforcement, Food and Drug Administration

Professor Malcolm K. Sparrow, Ph.D.
Lecturer in Public Policy, John F. Kennedy School of Government, Harvard University

Robert L. Steinmeier
Corporate 21 CFR Part II Program Director, Abbott Laboratories

David Waterbury, Esq.
Senior Counsel, Washington State Attorney General's Office, Medicaid Fraud Control Unit